secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lantern Pharma Inc. (LTRN)
CIK:        0001763950
Form:       8-K
Filed at:   2026-04-10T23:59:59+00:00
Accession:  0001493152-26-016047
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lantern Pharma demonstrates withZeta.ai AI co-scientist platform; no financial data disclosed
--------------------------------------------------------------------------------

- Live demo of withZeta.ai, a multi-agentic AI platform for rare cancer drug discovery and clinical design.
- Presentation discussed platform capabilities, commercial architecture, rare cancer market opportunity, and competitive positioning.
- Outlined near-term revenue strategy and growth roadmap for the withZeta.ai platform.
- Replay of the demonstration available at provided Zoom link; presentation furnished as Exhibit 99.1.
- No specific financial or operational metrics were provided in the filing or exhibit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1763950/000149315226016047/0001493152-26-016047-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1763950/000149315226016047/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-016047

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer